Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Prediction of first coronary events with the Framingham score: a systematic review.

Eichler K, Puhan MA, Steurer J, Bachmann LM.

Am Heart J. 2007 May;153(5):722-31, 731.e1-8. Review.

PMID:
17452145
2.

Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.

Riddell T, Wells S, Jackson R, Lee AW, Crengle S, Bramley D, Ameratunga S, Pylypchuk R, Broad J, Marshall R, Kerr A.

N Z Med J. 2010 Feb 19;123(1309):50-61.

PMID:
20186242
3.
4.

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.

Empana JP, Ducimetière P, Arveiler D, Ferrières J, Evans A, Ruidavets JB, Haas B, Yarnell J, Bingham A, Amouyel P, Dallongeville J; PRIME Study Group.

Eur Heart J. 2003 Nov;24(21):1903-11.

PMID:
14585248
5.

Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.

Scheltens T, Verschuren WM, Boshuizen HC, Hoes AW, Zuithoff NP, Bots ML, Grobbee DE.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):562-6. doi: 10.1097/HJR.0b013e3283063a65.

PMID:
18756178
6.

[Cardiovascular risk assessment for informed decision making. Validity of prediction tools].

Lenz M, Mühlhauser I.

Med Klin (Munich). 2004 Nov 15;99(11):651-61. Review. German.

PMID:
15583875
7.

SCORE should be preferred to Framingham to predict cardiovascular death in French population.

Marchant I, Boissel JP, Kassaï B, Bejan T, Massol J, Vidal C, Amsallem E, Naudin F, Galan P, Czernichow S, Nony P, Gueyffier F.

Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):609-15. doi: 10.1097/HJR.0b013e32832da006.

PMID:
20054289
8.

A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study.

Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM.

Am Heart J. 2002 Jul;144(1):95-100.

PMID:
12094194
9.

Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.

Vergnaud AC, Bertrais S, Galan P, Hercberg S, Czernichow S.

Prev Med. 2008 Jul;47(1):61-5. doi: 10.1016/j.ypmed.2008.02.023. Epub 2008 Mar 10.

PMID:
18456313
10.

Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population.

Marques-Vidal P, Rodondi N, Bochud M, Chiolero A, Pécoud A, Hayoz D, Paccaud F, Mooser V, Firmann M, Waeber G, Vollenweider P.

Int J Cardiol. 2009 Apr 17;133(3):346-53. doi: 10.1016/j.ijcard.2008.01.004. Epub 2008 May 15.

PMID:
18485502
11.

Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.

Elbarouni B, Goodman SG, Yan RT, Welsh RC, Kornder JM, Deyoung JP, Wong GC, Rose B, Grondin FR, Gallo R, Tan M, Casanova A, Eagle KA, Yan AT; Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators.

Am Heart J. 2009 Sep;158(3):392-9. doi: 10.1016/j.ahj.2009.06.010.

PMID:
19699862
12.

Validity of the Framingham point scores in the elderly: results from the Rotterdam study.

Koller MT, Steyerberg EW, Wolbers M, Stijnen T, Bucher HC, Hunink MG, Witteman JC.

Am Heart J. 2007 Jul;154(1):87-93.

PMID:
17584559
13.
14.

Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.

Metcalf PA, Wells S, Scragg RK, Jackson R.

N Z Med J. 2008 Sep 5;121(1281):49-57.

PMID:
18797484
15.

Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population.

de Visser CL, Bilo HJ, Thomsen TF, Groenier KH, Meyboom-de Jong B.

J Intern Med. 2003 May;253(5):553-62.

16.

The Framingham Risk Score: an appraisal of its benefits and limitations.

Hemann BA, Bimson WF, Taylor AJ.

Am Heart Hosp J. 2007 Spring;5(2):91-6. Review.

PMID:
17478974
17.

Cardiovascular risk prediction tools for populations in Asia.

Asia Pacific Cohort Studies Collaboration, Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, Woodward M.

J Epidemiol Community Health. 2007 Feb;61(2):115-21.

18.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.

Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.

19.

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.

Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB.

J Epidemiol Community Health. 2003 Aug;57(8):634-8.

20.

State of the art coronary heart disease risk estimations based on the Framingham heart study.

Reissigová J, Tomecková M.

Cent Eur J Public Health. 2005 Dec;13(4):180-6. Review.

PMID:
16419382

Supplemental Content

Support Center